{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:51:48Z","timestamp":1761519108943},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1982,11,1]],"date-time":"1982-11-01T00:00:00Z","timestamp":404956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1982,11]]},"DOI":"10.1007\/bf03350535","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T23:21:19Z","timestamp":1397172079000},"page":"373-378","source":"Crossref","is-referenced-by-count":14,"title":["Effect of plasmapheresis and steroid treatment on thyrotropin binding inhibitory immunoglobulins in a patient with exophthalmos and a patient with pretibial myxedema"],"prefix":"10.1007","volume":"5","author":[{"given":"N.","family":"Kuzuya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. J.","family":"DeGroot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,11]]},"reference":[{"key":"BF03350535_CR1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","volume":"26","author":"JM Lindstrom","year":"1976","unstructured":"Lindstrom J.M. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic values. Neurology (Minneap.) 26: 1054, 1976.","journal-title":"Neurology (Minneap.)"},{"key":"BF03350535_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.170678","volume":"190","author":"JS Flier","year":"1975","unstructured":"Flier J.S., Kahn C.R., Roth J., Bar R.S. Antibodies that impair receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 190: 63, 1975.","journal-title":"Science"},{"key":"BF03350535_CR3","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM197711242972102","volume":"297","author":"PC Dau","year":"1977","unstructured":"Dau P.C., Lindstrom J.M., Cassel C.K., Denys E.H., Shev E.E., Spitler L.E. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N.Engl. J. Med. 297:1134, 1977.","journal-title":"N.Engl. J. Med."},{"key":"BF03350535_CR4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1056\/NEJM197903013000906","volume":"300","author":"M Muggeo","year":"1979","unstructured":"Muggeo M., Flier J.S., Abrams R.A., Harrison L.C., Deisserroth A.B., Kahn C.R. Treatment by plasma-exchange of a patient with auto-antibodies to the insulin receptor. N.Engl. J. Med. 300: 477, 1979.","journal-title":"N.Engl. J. Med."},{"key":"BF03350535_CR5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1210\/jcem-36-5-859","volume":"36","author":"T Onaya","year":"1973","unstructured":"Onaya T., Kotani M., Yamada T., Ochi Y. New in vitro tests to detect the thyroid stimulators in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic-AMP in human thyroid slices. J. Clin. Endocrinol. Metab. 36: 859, 1973.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350535_CR6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(74)91815-7","volume":"2","author":"BR Smith","year":"1974","unstructured":"Smith B.R., Hall R. Thyroid-stimulating immunoglobulins in Graves\u2019 disease. Lancet 2: 427, 1974.","journal-title":"Lancet"},{"key":"BF03350535_CR7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/jcem-42-2-341","volume":"42","author":"J Orgiazzi","year":"1976","unstructured":"Orgiazzi J., Williams D.E., Chopra I.J., Solomon D.H. Human thyroid adenyl cyclase stimulating activity in immunoglobulin G of patients with Graves\u2019 disease. J. Clin. Endocrinol. Metab. 42: 341, 1976.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350535_CR8","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1210\/jcem-42-4-778","volume":"42","author":"JM McKenzie","year":"1976","unstructured":"McKenzie J.M., Zakarija M. A reconsideration of a thyroid stimulating immunoglobulin as the cause of hyperthyroidism in Graves\u2019 disease. J. Clin. Endocrinol. Metab. 42: 778, 1976.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350535_CR9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2265.1975.tb01529.x","volume":"4","author":"R Hall","year":"1975","unstructured":"Hall R., Smith B.R., Mukhtar E.D. Thyroid stimulators in health and disease. Clin. Endocrinol. (Oxf) 4: 213, 1975.","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"BF03350535_CR10","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1073\/pnas.69.7.1711","volume":"69","author":"RJ Winand","year":"1972","unstructured":"Winand R.J., Kohn L.D. The binding of [3H]-Thyrotropin and an 3H-labeled ex-ophthalmogenic factor by plasma membranes of retro-orbital tissue. Proc. Natl. Acad. Sci. USA 69: 1711, 1972.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03350535_CR11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1210\/jcem-48-4-706","volume":"48","author":"N Kuzuya","year":"1979","unstructured":"Kuzuya N., Chiu S.C., Ikeda H., Uchimura H., Ito K., Naga-taki S. Correlation between thyroid stimulators and 3, 5, 3\u2032-tri-iocldthyronine suppressibility in patients during treatment for hyperthyroidism with thiouramide drugs: comparison of assays by thyroid-stimulating and thyrotro-pin-displacing activities. J. Clin. Endocrinol. Metab. 48: 706, 1979.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350535_CR12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(75)91629-3","volume":"1","author":"ED Mukhtar","year":"1975","unstructured":"Mukhtar E.D., Smith B.R., Pyle G.A., Hall R., Vice P. Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Lancet 1: 713, 1975.","journal-title":"Lancet"},{"key":"BF03350535_CR13","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1210\/endo-83-4-845","volume":"83","author":"Y Ochi","year":"1968","unstructured":"Ochi Y., DeGroot L.J. Studies on the immunological properties of LATS. Endocrinology 83: 845, 1968.","journal-title":"Endocrinology"},{"key":"BF03350535_CR14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000178240","volume":"2","author":"NI Robin","year":"1971","unstructured":"Robin N.I., Hagen S.R., Collaco F., Refetoff S., Selenkow H.A. Serum tests for measurement of thyroid funrtion. Hormones 2: 266, 1971.","journal-title":"Hormones"},{"key":"BF03350535_CR15","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1210\/jcem-24-10-1005","volume":"24","author":"JP Kriss","year":"1964","unstructured":"Kriss J.P., Pleshakov V., Chien J. R. Isolation and identification of the long-acting thyroid stimulator and its relation to hyperthyroidism and circumscribed pretibial myxedema. J. Clin. Endocrinol. Metab. 24: 1005, 1964.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350535_CR16","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1172\/JCI104865","volume":"42","author":"DE Green","year":"1963","unstructured":"Green D.E., Snyder N.J., Solomon D.H. Glucocorticoid-induced disappearance of the long-acting thyroid stimulator in Graves\u2019 ophthalmopathy. J. Clin. Invest. 42: 939, 1963.","journal-title":"J. Clin. Invest."},{"key":"BF03350535_CR17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1210\/jcem-47-2-249","volume":"47","author":"M akarija","year":"1978","unstructured":"akarija M., McKenzie J.M. Zoological specificity of human thyroid-stimulating antibody. J. Clin. Endocrinol. Metab. 47: 249, 1978.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350535_CR18","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1210\/jcem-46-5-734","volume":"46","author":"K Endo","year":"1978","unstructured":"Endo K., Kasagi K., Konishi J., Ikekubo K., Okuno T., Takeda Y., Mori T., Torizuka K. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves\u2019 disease and Hashimoto\u2019s thyroiditis. J. Clin. Endocrinol. Metab. 46: 734, 1978.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350535_CR19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/oxfordjournals.bmb.a070058","volume":"19","author":"RG White","year":"1963","unstructured":"White R.G. Factors affecting the antibody response. Br. Med. Bull. 19: 207, 1963.","journal-title":"Br. Med. Bull."},{"key":"BF03350535_CR20","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/bmj.1.6160.374","volume":"1","author":"P Dandona","year":"1979","unstructured":"Dandona P., Marshall N.J., Bidey S.P., Nathan A., Havard C.W.H. Successful treatment of exophthalmos and pretibial myxedema with plasmapheresis. Br. Med. J. 1:374, 1979.","journal-title":"Br. Med. J."},{"key":"BF03350535_CR21","volume-title":"Thyroid research VIII","author":"P Dandona","year":"1980","unstructured":"Dandona P., Marshall N.J., Bidey S.P., Nathan A., Havard C.W.H. Treatment of acute malignant exophthalmos with plasma exchange. In: Stockigt J.R., Nagataki S. (Eds.), Thyroid research VIII. Australian Academy of Science, Canberra, 1980, p."},{"key":"BF03350535_CR22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1210\/jcem-48-5-803","volume":"48","author":"N Aoki","year":"1979","unstructured":"Aoki N., Pinnamaneni K.M., DeGroot L.J. Studies on suppressor cell function in thyroid diseases. J. Clin. Endocrinol. Metab. 48: 803, 1979.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350535_CR23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/1523-1747.ep12543646","volume":"71","author":"HS Cheung","year":"1978","unstructured":"Cheung H.S., Nicoloff J.T., Kamiel M.B., Spolter L, Nimni M.E. Stimulation of fibroblast biosynthetic activity by serum of patients with pretibial myxedema. J. Invest. Dermatol. 71:12, 1978.","journal-title":"J. Invest. Dermatol."},{"key":"BF03350535_CR24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(76)93089-0","volume":"1","author":"CM Lockwood","year":"1976","unstructured":"Lockwood C.M., Rees A.J., Pearson T.A., Evans D.J., Peters D.K. Immunosuppression and plasma-exchange in the treatment of Goodpasture\u2019s syndrome. Lancet 1: 711, 1976.","journal-title":"Lancet"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03350535.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03350535\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03350535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T11:57:55Z","timestamp":1565351875000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03350535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,11]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1982,11]]}},"alternative-id":["BF03350535"],"URL":"https:\/\/doi.org\/10.1007\/bf03350535","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,11]]}}}